Your browser doesn't support javascript.
loading
Combined treatment of sorafenib and doxorubicin-loaded microbubble-albumin nanoparticle complex for hepatocellular carcinoma: A feasibility study.
Lee, Seunghyun; Kim, Jung Hoon; Moon, Hyungwon; Lee, Hak Jong; Han, Joon Koo.
Affiliation
  • Lee S; Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea.
  • Kim JH; Department of Radiology, Seoul National University Hospital, Jongno-gu, Seoul, Republic of Korea.
  • Moon H; Department of Radiology, Seoul National University College of Medicine, Jongno-gu, Seoul, Republic of Korea.
  • Lee HJ; Institute of Radiation Medicine, Seoul National University Medical Research Center, Jongno-gu, Seoul, Republic of Korea.
  • Han JK; IMGT Co., Ltd., Bundang-gu, Seongnam, Republic of Korea.
PLoS One ; 15(12): e0243815, 2020.
Article in En | MEDLINE | ID: mdl-33306731

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Doxorubicin / Carcinoma, Hepatocellular / Microbubbles / Albumins / Nanoparticles / Sorafenib / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: PLoS One Year: 2020 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Doxorubicin / Carcinoma, Hepatocellular / Microbubbles / Albumins / Nanoparticles / Sorafenib / Liver Neoplasms Type of study: Prognostic_studies Language: En Journal: PLoS One Year: 2020 Type: Article